By Greg Vega 
Canberra. Australia became the latest country on Thursday to recommend that AstroGeneca’s corona virus vaccine not be given to people under the age of 50.
The announcement comes after drug controllers held a series of emergency meetings that day. The European Medicines Agency’s warning that there is a link between the vaccine and tumors.
Australian Prime Minister Scott Morrison said on Thursday night that he had received a series of recommendations from an advisory panel, most importantly that the Pfizer vaccine should now be accepted as the preferred vaccine for those under 50 years of age.
According to Morrison, the recommendations were made with great caution because of the rare but severe side effect, which is often associated with younger people.
“We are taking the necessary precautionary measures based on the best medical advice,” he said.
The Australian Immunization Technical Advisory Council has recommended that those under the age of 50 who have already received the Astrogenega vaccine should continue second, as clinical recommendations indicate that rare tumors occur only after the first dose.
The panel said that the initial dose of Astrogenogen should be given to a person under the age of 50 only when the benefit is clearly greater than the risk.
Health workers under the age of 50 who need to get the Astrogenega vaccine will now have a higher priority than Pfizer, which will definitely delay the process.